MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales

MARTINSRIED (dpa-AFX) - MorphoSys AG (MOR, MPSYY.PK) reported that preliminary Monjuvi U.S. net product sales were $23.6 million for the fourth quarter and $79.1 million for the full year 2021.

Related Keywords

Martinsried ,Bayern ,Germany ,Jean Paul Kress , ,Chief Executive Officer ,Morphosys ,Reports ,Reliminary ,021 ,Monjuvi ,Sales ,